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Objective: To examine and report surgical results from a contemporary experience of open abdominal aortic reconstruc-
tion in patients with chronic atherosclerotic abdominal aortic occlusion (CAAAO).
Methods: Between January 1999 through May 2010, 54 patients with CAAAO were identified and retrospectively
reviewed. CAAAOs were categorized into infrarenal aortic occlusions (IRAOs) and juxtarenal aortic occlusions (JRAOs)
based on superior extension of thrombus and requirement for supra-renal aortic clamping to repair. Morbidity,
mortality, hospital stay, and operative variables were assessed. The 2 or Fisher test and the Wilcoxon rank sum test were
used to compare demographic and operative variables between two aortic occlusion groups (IRAO and JRAO).
Univariate andmultivariate analyses were performed to assess factors associated with surgical outcomes and hospital stay.
The Kaplan-Meier method was used to calculate survival and patency rates.
Results: Fifty patients underwent aortic reconstructions with aorto-bifemoral or iliac bypass, and three underwent a
remote axillo-femoral bypass procedure. There were 35 (64.8%) males, and 19 (35.2%) females. Median age was 51.9
years (range, 32-72 years). Of the two CAAAO groups, there were 20 IRAOs and 33 JRAOs. Aorto-renal thromboen-
dartectomy was performed in 26 (49.1%) patients; 26 (75.8%) among JRAOs versus 1 (5%) of IRAOs (P< .01). Proximal
aortic clamps were required in 28 (85%) of JRAOs and 3 (15%) of IRAOs (P< .01). Thirty-day and in-hospital mortality
was zero. Median length of hospital stay was 7 days (range, 4 to 66 days), and median intensive care unit length of stay
was 3 days (range, 1-22 days). Complications included cardiopulmonary dysfunction in four (8%), postoperative renal
insufficiency in 10 (18.9%), and other postoperative complications in 15 (28.3%). All 10 with renal insufficiency recovered
renal function to baseline creatinine or a creatinine value<1.1mg/dL.Mean increases in right and left ankle-brachial indicess were
0.540.25 and 0.59 0.22, respectively. On univariate analysis, coronary artery disease and African American race were
predictors of postoperative complications (P  .048). Age was significantly associated with total complications. Patients
with postoperative complications and/or renal insufficiency were older than those without such complications (P .02)
Independent predictors of prolonged hospital stay were intraoperative blood replacement (P  .003), postoperative
complications (P< .01), and postoperative renal insufficiency (P< .01). Prolonged intensive care unit stay was predicted
by JRAO (P  .04), postoperative complications (P  .02), and postoperative renal insufficiency (P  .013). Survival at
3, 5, and 7 years were 86.6%, 76.5% and 50.9%, respectively. The reduced survival rates were predicted by previous
myocardial infarction and existing coronary artery disease (P < .01).
Conclusion: Abdominal aortic reconstruction is a safe method for treating CAAAO with low associated morbidity and
mortality. Aorto-renal thromboendartectomy with supra-renal aortic clamping and aortic replacement remains an
effective treatment for those with significant pararenal aortic disease, and can be performed without significant renal
impairment. (J Vasc Surg 2010;52:1164-72.)Chronic atherosclerotic abdominal aortic occlusion
(CAAAO) is a rare form of aortic disease usually found in
patients with a history of heavy tobacco use.1,2 This condition
was first described by Leriche3 in 1923, which culminated in a
From the Department of Surgery,a Department of Bioinformatics and
Computational Biology,b Department of Radiology,c Louisiana State
University Health Sciences Center, and Department of Mathematics,d
Louisiana State University.
Competition of interest: none.
Reprint requests: Dr. Charles A. West Jr, Henry Ford Hospital, Surgery;
Division of Vascular Surgery, 2799W. Grand Blvd., Ste. K-8, Detroit, MI
48202 (e-mail: cwest5@hfhs.org).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2010 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.05.112
1164series of reports followed by description of the particular
syndrome.3-5 Patients with CAAAO commonly present with
severe claudication and occasionally with more advanced
lower extremity ischemia.6,7 Of greatest concern are the less
common, but potentially fatal, complications of progressive
ascending aortic thrombosis in the untreated.8,9
Historically, direct open surgical approaches to the
abdominal aorta have been advocated to relieve lower
extremity ischemia and eliminate the risk of aortic throm-
bus propagation into the paravisceral aortic segment.10-13
Alternatives to direct abdominal aortic reconstruction have
been proposed with the use of remote bypass procedures
and other inflow sources to treat patients with abdominal
aortic occlusion.14-16 Successful reports of these techniques
have brought into question the true risk of ascending aortic
thrombosis in the setting of chronic aortic occlusion
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reported but are currently not well established as a credible
treatment option.17
Controversy surrounding ascending aortic thrombosis
in CAO and themost appropriate surgical management still
remains. Few series are available that provide a current
review of techniques and outcomes from direct abdominal
aortic reconstruction. Thus, we sought to describe our
contemporary experience and report early surgical results.
METHODS
Between January 1, 1999 and May 2010, clinical
records of all patients with CAAAO at Louisiana State
University Health Science Center in Shreveport, LA were
reviewed and retrospectively analyzed after approval from
the Institutional Review Board. Patients with CAAAOwere
identified using procedure code identifiers 39.35 and In-
ternational Classification of Diseases, Ninth Revision codes
444.0 and 444.1. Manual medical chart review and elec-
tronic record queries were performed and all clinical data
were entered into a Microsoft Access data base (2007,
Microsoft, Redmond, Wash). For all patients, the diagnosis
of CAAAO was determined by clinical evaluation and con-
firmed by either digital subtraction angiography or com-
puted tomography. Those with acute embolic/thrombotic
aortic occlusion and aortic aneurysms were excluded. Pa-
tients were followed up at mean of 42.9 months (range,
2.5-116.7 months) by routine clinic visits and telephone
interviews. The State of Louisiana Department of Health
and Hospitals Center for Health Statistics provided the
survival status on missing subjects. Primary end points
include in-hospital and 30-day mortality. Secondary end-
points include cardiopulmonary and renal morbidity, post-
operative complications, combined adverse event rate and
length of stay (intensive care unit [ICU] and hospital), graft
patency, and survival. Significant predictors of adverse out-
comes were determined among patient characteristics and
operative variables.
Patterns of CAAAO: infrarenal aortic occlusion and
juxtarenal aortic occlusion
Patient categories/definitions. CAAAOs were char-
acterized as either infrarenal aortic occlusion (IRAO) or
juxtarenal aortic occlusion (JRAO), based on the level of
proximal extension of chronic athero-thrombotic material
and level of disruption of the contrast column on computed
tomographic angiogram (CTA) or standard digital subtrac-
tion angiography. IRAOs were defined as athero-thrombotic
occlusion at the terminal aortic level (between the aortic
terminus and inferior mesenteric artery) or in the mid
abdominal aorta that permitted infrarenal clamping above
the occlusion level. IRAOs were performed with infrarenal
aortic clamps in most cases, but in some cases, the presence
of juxtarenal atherosclerosis extending above the level of
occlusive thrombus mandated suprarenal clamping. Pa-
tients were identified as JRAOs when the occlusive process
encroached to the level of one or both main renal arteries
requiring proximal aortic clamping.Preoperative variables/patient characteristics. Baseline
variables collected include: age, gender, ethnicity, and
CAAAO type. Preoperative comorbodities were coronary
artery disease (CAD), defined as previous myocardial in-
farction (MI), cardiac stress testing evidenced by demon-
strable defects on nuclear imaging, electrocardiogram evi-
dence of MI confirmed by staff cardiologist, previous
coronary bypass and grafting or Percutanueous translumi-
nal coronary angioplasty procedure. Chronic obstructive
pulmonary disease or pulmonary insufficiency was present
in all patients requiring supplement oxygen at home, those
on scheduled bronchodilator inhalers, with a diagnosis of
chronic lung disease, and documented abnormal pulmo-
nary function test. Congestive heart failure was present in
all those with cardiac testing with an associated ejection
fraction less than 30%. Other baseline variables observed
on the patients were preoperative renal insufficiency, de-
fined as a serum creatinine (Cr) level 1.5 mg/dL, smok-
ing (current or past in pack-years), diabetes, hypertension
(diastolic blood pressure greater than 90 mmHg or on one
or more antihypertensive medications), hyperlipidemia,
history of deep vein thrombosis, malignancy, and chronic
renal failure. Severe claudication was present in those with
pain on exercise or walking in the lower extremities relieved
by rest, which was considered lifestyle-limiting to the pa-
tient. Advanced ischemia was defined as non-healing
wounds or ulcerations, gangrene, or rest pain in those with
an ankle-brachial index (ABI) 0.5 or an absolute ankle
pressure 70 mm Hg. Demographic data are summarized
in Table I.
Operative variables/procedures. Aortic reconstruc-
tion included aorto-femoral or iliac bypasses (ABF-I) using
gelatin sealed polyester prosthesis. Fourteen 7mm bifur-
cated grafts were employed in most operations. Procedures
consisted of 1) ABF-I only and 2) ABF-I with pararenal
thrombectomy with or without aortorenal thromboendar-
terectomy (AR-TEA) noted in Table II. Aortic clamp po-
sitions and ischemic intervals in minutes were recorded.
Aortic clamping was infrarenal (IRC); interenal, defined as
above one of the other main renal arteries; supra-renal,
defined as above both renal arteries; supra-mesenteric, or
supra-celiac. Interenal clamps were considered as suprare-
nal clamps. Early in the experience, manual suprarenal
aortic occlusion and thrombectomy extraction was em-
ployed in five patients with juxtarenal aortic occlusion.
Three patients were deemed high risk for aortic reconstruc-
tion and were treated with extra anatomic axillo-femoral
bypasses. In one, a large lower extremity wound infection
precluded aortic grafting. Two were considered high risk
for open surgery as a result of severe cardiac disease. Oper-
ative times were recorded in minutes. Intraoperative trans-
fusions were accounted for in units transfused (cell saver
and banked blood) during the procedure.
Exposure, reconstructive techniques, and operative
management
Exposure was through a midline xipho-pubic incision
followed by an infracolic aortic approach. Pararenal aortic
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tion, sharp exposure of all renal arteries, and incising the anterior
aortic neural and lymphatic tissue encasing the superior
mesenteric artery with bilateral division of the diaphrag-
matic crura.18 Circumferential mobilization of the superior
mesenteric artery with supramesenteric clamping was nec-
essary in instances of extensive pararenal thrombus or in
cases when more detailed renal endarterectomy beyond the
renal artery origin was anticipated. AR-TEA was utilized to
remove chronic adhesive thrombus from the aortic wall
surface and lumen.
IRAOs underwent sub-renal aortic anastomosis within
1.5 to 3 cm from the immediate infrarenal clamp position
after excision of short segment of infrarenal aorta avoiding
the need for thrombectomy. In JRAOs, reconstructions
were performed either end-to-end to the infrarenal aorta,
the juxtarenal aorta after AR-TEA, or to the infrarenal aorta
after longitudinal aortotomy, AR-TEA and primary aortic
closure. Grafts sewn directly to the juxtarenal aorta were
sewn within 1.0 to 2.0 cm of the lowest main renal artery,
and frequently, sutures were placed either into or around
the renal artery orifices. With the later technique, the
aortotomy was extended up to the base or beyond the
superior mesenteric artery origin on the left lateral side of
the aortic wall followed by AR-TEA. Aortic primary closure
Table I. Patient characteristics: comparisonsa between jux
or median, mean  SD
Variable All (n
Demographics
Age (years) 51.9, 51
Gender (male) 35 (
Ethnicity
African American 12 (
Caucasian 42 (
Smoking (preoperative) 54 (
Hypertension 47 (
Hyperlipidemia 26 (
Diabetes 8 (
Coronary artery disease 28 (
Previous myocardial infarction 18 (
Chronic obstructive pulmonary disease 11 (
Renal insufficiency 2 (
Congestive heart failure 3 (
Deep venous thrombosis 1 (
Infrainguinal occlusive disease 16 (
Claudication 36 (
Critical limb ischemia 18 (
Critical limb ischemia type
Rest pain 9 (
Non-healing wound 9 (
Hemodynamics
Preoperative ABI (right) 0.40, 0.3
Preoperative ABI (left) 0.45, 0.3
Postoperative ABI (right) 1.0, 0.9
Postoperative ABI (left) 1.0, 0.9
ABI, Ankle-brachial index; IRAO, infrarenal occlusion patients; JRAO, jux
aCalculated on non-missing values.
bSignificant at 5% level (.01  P value  .05).was routinely performed with 4-0 polyprolene; the suture-line was discontinued at a level directly below the renal vein,
allowing a safe clamp transition and optimal exposure for
reconstruction. In some JRAOs, engraftment to the infra-
renal aorta was performed after manual thrombectomy and
or thromboendarterectomy. In these, if the clamp could be
moved for an infrarenal anastomosis. The preferredmethod
of treatment was to divide the aorta just beneath the renal
arteries with a suprarenal clamp facilitating AR-TEA and
aortic replacement.
An important technical goal in JRAOs was to completely
remove all adherent chronic thrombus from the pararenal
aorta. In patients with chronic aortic thrombus impinging on
the renal artery margins, AR-TEA was sufficient in removing
adherent thrombus around the renal orifices.When thrombus
and or atherosclerotic plaque extended further out into the
renal arteries, an extendedAR-TEAas part of the aorticwall or
renal artery bypass was required and considered as a renal
revascularization procedure.
Intraoperatively, continuous cell saver auto-transfusion
was employed. Prior to aortic clamping, all patients were
administered 70 to 100 U/kg of intravenous heparin.
Renal function protection routinely included 12.5 to 25 g
ofMannitol, followed by 40 to 60mg of Lasix administered
intravenously to induce diuresis 10 to 15 minutes prior to
suprarenal cross-clamping. The renal arteries were intermit-
al and infrarenal aortic occlusion patients – number (%)
4) IRAO (n  20) JRAO (n  34) P value
8.4 51.0, 51.3  8.2 52.3, 52.1  8.6 .70
12 (60.0) 23 (67.6) .57
.74
5 (25.) 7 (20.6)
15 (75.0) 27 (79.4)
20 (100.0) 34 (100.0) N/A
16 (80.0) 31 (91.2) .40
12 (60.0) 14 (45.2) .30
3 (15.0) 5 (15.2) .99
10 (50.0) 18 (52.9) .83
6 (30.0) 12 (35.3) .69
3 (15.0) 8 (23.5) .51
0 (0.0) 2 (5.9) .52
0 (0.0) 3 (0.0) .29
0 (0.0) 1 (2.9) .99
5 (25.0) 11 (34.4) .48
17 (85.0) 19 (97.1) .99
3 (15.0) 15 (44.1) .04b
.21
3 (100.0) 6 (40.0)
0 (0.0) 9 (60.0
0.17 0.46, 0.44  0.12 0.34, 0.37  0.19 .13
0.18 0.48, 0.43  0.16 0.37, 0.36  0.19 .26
0.22 1.00, 0.96  0.14 1.01, 0.90  0.26 .91
0.19 1.02, 0.96  0.24 1.00, 0.96  0.16 .59
l aortic occlusion.taren
 5
.0 
64.8)
22.2)
77.8)
100)
87.0)
51.0)
15.1)
51.8)
33.3)
20.4)
3.7)
5.6)
1.8)
30.8)
66.0)
33.0)
50.0)
50.0)
9 
9 
2 
6 
tarenatently flushed with cooled heparin saline (4 U/cc).
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in the hospital or within 30 days from operation. Cardio-
pulmonary and renal dysfunction were defined as followed:
● Cardiac morbidity was considered postoperative MI,
defined by elevation of troponin values and electrocar-
diogram evidence of myocardial ischemia confirmed
by a staff cardiologist, or cardiac arrhythmias requiring
medical treatment. Pulmonary insufficiency after sur-
gery was present in patients requiring prolonged me-
chanical ventilator support for more than 72 hours,
requirement of reintubation for the diagnosis of pul-
monary failure, or the development of pneumonia
confirmed by clinical and radiologic data. These vari-
ables were combined as a single cardiopulmonary post-
operative complication outcome.
● Postoperative renal insufficiency (RI) was defined by a
serum creatinine rise of 0.5 mg/dL or greater after the
procedure. Renal dysfunction was also assessed using
Table II. Operative variables: comparisonsa between juxta
median, mean  SD, range*
Variable All (n  53)
Operative procedure
Aorto-femoral bypass
(pararenal
thrombectomy) 30 (56.6)
Aorto-femoral bypass
(alone) 20 (38.0)
Axillo-bifemoral bypass 3 (5.7)
Aorto-renal
thromboendarterectomy 26 (49.1)
Clamp position
Infrarenal 19 (38.0)
Inter-renal 5 (10.0)
Suprarenal 20 (40.0)
Supramesenteric 4 (8.0)
Supraceliac 2 (4.0)
Proximal reconstruction
End-end infrarenal aorta 20 (40.0)
End-side infrarenal aorta 3 (6.0)
End-end juxtarenal aorta 15 (30.0)
End-end infrarenal aorta
(primary aortic closure) 12 (24.0)
Renal artery revascularization 8 (15.1)
Bypass 2 (3.8)
Endarterectomy 5 (9.4)
Reimplantation 1 (1.9)
Operative time (minutes) 348.5, 360.8  104.4, 160-651
Renal or mesenteric ischemic
time 0 26 (54.2)
Renal ischemic timeb 22.5, 22.5  10.2, 5-47
Mesentric ischemic timeb 24, 23.7  9.3, 10-36
Blood replace save (units) 1.0, 1.9  2.0, 0-9
Intraoperative blood banked
(units) 0, 1.0  1.5, 0-8
IRAO, Infrarenal occlusion patients; JRAO, juxtarenal aortic occlusion.
alongitudinal pararenal aortototomy with primary aortic closure.
bAmong patients with non-zero ischemic times.
*Significant at 5% level (0.01  P-value  0.05).
**Significant at 1% level (P-value 0.01).TheModification of Diet in Renal Disease study equa-tion to calculate changes in glomerular filtration rate
(GFR; mL/min per 1.73 m2).19,20 Recovery of renal
function was based on serum Cr in mg/dL values
measured at discharge; renal function recovery was
defined as “recovered” if the serum Cr levels returned
to baseline or serum Cr 1.2 mg/dL.
Minor non-cardiopulmonary postoperative complica-
tions were collected and are summarized in Table III.
Postoperative complications were collated in a single vari-
able, excluding postoperative renal insufficiency, which was
analyzed independently. Total postoperative complications
were defined as all postoperative complications and or the
development of postoperative renal insufficiency.
Follow up
Patients returned at 2 to 4 weeks postoperatively, fol-
lowed by a 6-month clinic visit. Graft surveillance and
longitudinal follow up was insured by an annual scheduled
l and infrarenal aortic cclusion patients – number (%) or
IRAO (n  20) JRAO (n  33) P value
0.01**
1 (5.0) 29 (87.9)
19 (95.0) 1 (3.0)
0 (0.0) 3 (9.1)
1 (5.0) 25 (75.8) 0.01**
0.01**
17 (85.0) 2 (6.7)
2 (10.0) 3 (10.0)
1 (5.0) 19 (63.3)
0 (0.0) 4 (13.3)
0 (0.0) 2 (6.7)
0.01**
14 (70.0) 6 (20.0)
3 (15.0) 0 (0.0)
3 (15.0) 12 (40.0)
0 (0.0) 12 (40.0)
1 (4.8) 7 (21.9) 0.13
0 (0.0) 2 (6.2) 0.51
0 (0.0) 5 (15.6) 0.14
1 (4.8) 0 (0.0) 0.99
, 357  84.6, 255-600 350, 363  115.4, 160-651 0.97
3 (15.8) 23 (76.4) 0.01**
0, 29  8.5, 20-37 22, 21.7  10.2, 5-47 0.22
10 (n  1) 27, 26  7.7, 14-36 0.13
0, 1.6  1.5, 0-5 1.0, 2.1  2.3, 0-9 0.64
0, 0.7  1.0, 0-3 0.5, 1.2  1.8, 0-8 0.32rena
345
3
1.appointment in the university vascular clinic with an affili-
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sion for the Accreditation of Vascular Laboratories). Graft
patency was determined by evidence of a palpable graft
pulse at the femoral artery exposure sites in the groins and
or palpable pedal pulses at each current visit. Objective
evidencewas obtained in 38 patientswith non-invasive arterial
studies and in three by aortic ultrasounds. Phone call inter-
views were performed at the end of the study to determine
clinical status and survival information by a staff vascular
surgeon. Only eight patients did not have current follow
up. In these, the state health statistics bureau assisted in
determining survival status.
Statistical analysis. All continuous variables are rep-
resented with the mean  standard deviation or median
(range). Categorical variables are listed as frequencies
and percentages. The 2 or Fisher test was used to
determine association between a categorical outcome
and a categorical factor. The Wilcoxon rank sum test was
used to determine association between a categorical
outcome and a numeric factor, while the Spearman rank
Table III. Postoperative outcomes and their significant as
Outcome
Number (%) or m
(range), me
Mortality 0 (0.0)
Cardiac-pulmonary complications 4 (8.2)
Pulmonary insufficiency 3 (6.1)
Myocardia infarction 1 (2.0)
Renal insufficiency 10 (18.9
Temporary dialysisb 2 (4.1)
Permanent dialysis 0 (0.0)
Minor postoperative complications 15 (30.0
Wound infection 4 (8.2)
Deep venous thrombosis 1 (2.0)
Ileus 4 (8.2)
Anemia 1 (2.0)
Colitis 3 (6.1)
Total complicationsc 23 (43.4
Length of hospital stay (days) 9.8  9.5 (4-66),
Intensive care unit length of stay (days) 4.0  3.1 (1-22),
Change in right ABI 0.54  0.25 (0.0-1
Change in left ABI 0.59  0.22 (0.12
Graft patency (months) n  49 39.1  21.4 (2.5-1
1-year primary patency 98.0%
6-year primary patency 73.5%
Survival follow up (months) n  52 42.9  24.0 (2.5-1
3-year survival rated 86.6%
5-year survival rated 76.3%
7-year survival rated 50.9%
aCalculated on non-missing values.
bIncluded in postoperative complication.
cPostoperative complications and/or postoperative renal insufficiency.
dCalculated by the Kaplan-Meier method.correlation coefficient was used to determine associationbetween a numeric outcome and a numeric factor. Mul-
tiple logistic regression and general linear regression
analyses were used to determine independent significant
factors for categorical and numeric outcomes, respec-
tively. The Kaplan-Meier method was used to calculate
patient survival and graft patency rates. The log rank test
of the proportional hazard model was used to determine
factors significantly associated with patient survival or
graft patency. A 5% level of significance was used for all
statistical tests. SAS Version 9.2 (Cary, NC) was used for
statistical computing.
RESULTS
Demographics/patient characteristics and preoper-
ative comorbidities. The patients were classified into two
CAAAO groups; 34 and 20 patients belong to the JRAO
and IRAO groups, respectively (Table I). Only one patient
was not treated surgically at the time of data collection and
was excluded from final analysis. There were 35 men
tionsa with demographic/operative variables
SD
Significant associations P value
Ethnicity (African American) .048
Coronary artery disease .048
Age (55  8.0 vs 49.5  8.4 years) .02
Intraoperative blood replace .001
Age .03
Aortic occlusion level .003
Operative procedure .008
Clamp placement .006
Proximal anastomosis .05
Aortic renal endarterectomy .014
Renal/mesenteric ischemic time 0 .02
Intraoperative blood replace .03
0.58
), 0.58
), 38.9
38.2
History of myocardial infarction .008
History of coronary artery disease .005
History of coronary artery disease .01socia
ean 
dian
)
)
)
7
3
.04),
-1.10
00.2
16),(64.8%) and 19 women (35.2%); median age was 51.9 years
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compared on patient characteristics, preoperative comor-
bidities and hemodynamicmeasures listed in Table I.Major
comorbidities include smoking (100%), CAD (51.8%), pul-
monary insufficiency or chronic obstructive pulmonary dis-
ease (20.4%), renal dysfunction (serum Cr 1.5 mg/dL;
3.7%), and diabetes (15.1%). Severe disabling claudication
was present in 36 patients (66%), 18 (33%) had evidence of
advanced ischemia of lower extremities, and one patient in
the pararenal occlusion group presented with ascending
aortic thrombosis in acute renal failure. Critical limb isch-
emia was present in 44% (15/34) of JRAOs and 15%
(3/20) of IRAOs (P  .04). Hemodynamic evaluations
with preoperative non-invasive arterial studies revealed a
median ABI of 0.40 and 0.45, respectively, between the
right and left lower extremities for the two groups com-
bined. There were no significant differences in pre- and
postoperative ABIs between the IRAOs and JRAOs, as
shown in Table I.
Surgical/operative data. Fifty-three patients were
treated surgically; 50 underwent aortic reconstructions
with ABF-I. Overall, ABF-I with pararenal thrombectomy
was performed in 30 (56.6%) patients (Table II). Operative
data are compared in Table II, between the 20 IRAO and
33 JRAO patients. Pararenal thrombectomywas performed
in 29 (87.9%) of JRAOs and in only one patient (5.0%) in
the IRAO group. In the JRAO group, one patient (3%) had
ABF with IRC without evidence of thrombectomy. The
JRAO and IRAO groups differed significantly on operative
procedures performed (P  .01). AR-TEA was required in
26 (49.1%) patients, 25 of 30 (75.8%) among the JRAOs
and 1 of 20 (5%) among the IRAOs (P  .01). The two
occlusion groups also differed significantly on aortic clamp-
ing (P  .01) as outlined in Table II.
For the IRAOs, 17 of 20 (85%) had ABF only with
IRC, two (10%) underwent ABF only with interrenal
clamps, and one patient (5%) underwent ABF with supra-
renal clamp. The JRAO group had mostly (19 or 63.3%)
suprarenal clamps. Proximal reconstruction was likewise
significantly different between the two occlusion groups
(P  .01). For those requiring suprarenal clamping with
non-zero ischemic intervals, median renal ischemic time
was 22.5 minutes (range, 5-47 minutes), and the median
mesenteric ischemic time was 24 minutes (range, 10-36
minutes). Renal artery revascularization was required in
15.1% (8/53); one (4.8%) IRAO and seven (21.9%) JRAO
patients (P  .13). There were no observed significant
differences between the IRAO and JRAO groups on pro-
portion of patients requiring renal revascularization, or on
average operative time and number of units of blood re-
placed. Median operative time and transfusion require-
ments (blood replacement) are summarized in Table II.
Surgical results. Postoperative outcomes and their
observed significant associations (using separate univar-
iate analyses) with demographic and operative variables
are shown in Table III. Thirty-day and in-hospital mor-
tality was zero. Complications included cardiopulmo-
nary dysfunction in four (8.2%) patients, (one MI andthree had pulmonary insufficiency), postoperative RI in
10 (18.9%), and minor postoperative complications in
15 (30%) patients listed in Table III. Total postoperative
complications were present in 23 of 53 (43.4%) patients.
Median length of hospital stay (LOS) was 7 days (range,
4-66 days), and median ICU length of stay was 3 days
(range, 1-22 days).
Renal insufficiency and functional recovery
Postoperative RI occurred in 18.9%, 3 of 20 (15%) were
IRAOs and 7 of 34 (21.2%) were JRAOs (P  .73). All 10
Fig 1. A, A graph of all patients experiencing renal postoperative
renal insufficiency, defined as Cr0.5 mg/dL. Three point trends
of preoperative Cr values, peak postoperative values, and Cr values
at discharge are represented. B, Graph of all patients experiencing
postoperative renal insufficiency calculating glomerular filtration
rate (GFR) using MDRD study equation (mL/min per 1.73 m2).
Three point trend of preoperative GFR values, GFR reductions
postoperatively, and values at discharge are represented. C, GFR
and Cr values for renal functional recovery expressed in percent
from baseline values. RI, Renal insufficiency.with RI recovered renal function to baseline creatinine or a
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GFR are illustrated in Fig 1B. GFR was restored to a level
within 30% of baseline prior to dismissal in all patients
(Fig 1C).
Of two patients (4.1%) requiring temporary dialysis,
only one actually developed acute renal failure after repair,
and one patient presented in renal failure secondary to
ascending aortic thrombosis. Renal function was rescued
from dialysis several months later in both. There were no
factors that were significantly associated with RI.
Complications and LOS
Minor postoperative complication(s) were significantly
associated with ethnicity and CAD. The proportion of
patients developing postoperative complications was signif-
icantly higher among African Americans and among those
with CAD, compared with Caucasians and patients without
CAD (P  .05). The mean age of patients with total
postoperative complication proportion was significantly
higher than that for patients without total postoperative
complication (P  .02). LOS was significantly associated
with number of units for intraoperative blood replaced
(P .01). Complications observed to be significantly associ-
ated with prolonged hospital and ICU stay are summarized in
Table IV. Both LOS and ICU stay were associated with all
four complication variables listed in Table IV.Usingmultivar-
iate analysis with the general regression model, the indepen-
dent significant variables predictive of prolonged hospitaliza-
Table IV. Associationsa of complication outcomes with h
Complication outcome
Hospital stay
(group median)
Cardiac-pulmonary complication Yes (n  4); 24
No (n  45); 6.5
Postoperative complication Yes (n  15); 10
No (n  35); 6
Postoperative renal insufficiency Yes (n  10); 10
No (n  44); 6
Total postoperative complicationb Yes (n  23); 10
No (n  31); 6
aCalculated on non-missing values.
bPostoperative complication and/or postoperative renal insufficiency.
Table V. Independent significant prognostic factors for le
(multivariate analysis)
Length (days) of Median, mean  SD, range
Hospital stay 7, 9.8  9.5, 4-66 days
Intensive care unit stay 3, 4.0  3.1, 1-22 daystion and ICU stay are shown in Table V.Graft patency/hemodynamics, amputations, and
survival
Forty-nine patients were sufficiently evaluated by the end
of the study for graft patency. In these, primary graft patency
at 1 and 6 years was 98% and 73.5%, respectively. One axillo-
femoral graft occluded less than 5months after surgery, and a
single limb of an aortic reconstruction failed 6 years postop-
eratively butwas recanalizedwith thrombolytic therapy. Table
III shows the mean change in ABIs between right and left
lower extremities. There were no major amputations after
surgerywhen the followupwas completed. In the 52 patients,
the overall 5-year survival was 76.3% (Fig 2). A history of MI
andCADwere associatedwith reduced survival (P .008 and
P .005, respectively) and is detailed in Table III.
DISCUSSION
CAAAO is an uncommon vascular condition occurring
with a frequency of 0.15% from necropsy studies.1 Prior to
recent advances in endovascular therapy for complex aorto-
iliac atherosclerosis, open surgical treatment of chronic
aortic occlusion accounted for only 4% to 10% of those
undergoing aortic reconstruction for obstructive dis-
ease.21-24 Currently, CAAAO remains one of the few well
accepted indications for aorto-femoral bypass grafting. Our
data are consistent with other reports, which indicate that
over 50% of those with CAO have proximal occlusions that
are pararenal or juxtarenal.11,16,25 In CAAAO, athero-
al and intensive care unit stays (univariate analyses)
P value
Intensive care unit stay
(group median) P value
.006 Yes (n  4); 75 .001
No (n  45); 3
.02 Yes (n  15); 5 .03
No (n  35); 3
.03 Yes (n  10); 4.5 .02
No (n  44); 3
.003 Yes (n  23); 4 .003
No (n  31); 3
s of hospital and intensive care unit stay
Significant factors Adjusted P value
Intraoperative blood replace .003
Postoperative complications .01
Postoperative renal insufficiency .01
Total complication .01
JRAO .04
Postoperative complication .02
Postoperative renal insufficiency .013
Total complication .04ospitngththrombotic disease adjacent to or circumferentially encom-
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exposure, and, in most cases, obligatory suprarenal or su-
pravisceral clamping. Frequently, there is a need for de-
tailed aortic thrombendarterectomy, which carries the as-
sociated risks of atheroembolic complications.11,12 These
factors account for an increased level of complexity in-
volved in the surgical management of CAO.
In reports of CAO, the most common indication for
surgical treatment is debilitating claudication.11,22-25 The
presentation of advanced ischemia occurs less frequently,
and occasionally CAAAO may be asymptomatic.6 In eval-
uating demographic variables between the two groups of
chronic aortic occlusion, JRAOs were found to have an
increased frequency of critical limb ischemia (44% com-
pared with 15%) than the IRAO group (P  .04). A slight
increase in the incidence of femoral-popliteal disease in
those with JRAOs (11 [34.4%] JRAOs and 5 [25%] IRAOs;
P .48), and also loss of iliolumbar and inferior mesenteric
collaterals may explain the increased frequency of advanced
ischemia in those with juxtarenal occlusion.
It is well accepted that renal and ormesenteric occlusive
disease may predispose patients with CAO to the risk of
ascending aortic thrombosis and potentially fatal viscerore-
nal complications.9,16,26 In our study, CTA evidence of
either isolated renal artery stenosis or chronic thrombus
impinging on the outflow tract of the renal arteries was not
uncommon; however, only one patient of the 54 presented
in acute renal failure with associated ascending thrombosis
and concomitant bilateral renal artery stenosis resulting
from primary renal ostial atherosclerotic plaques. It is con-
ceivable that pararenal thrombus as an in situ lesion may
also produce flow-limiting hemodynamics and increase
atheroembolic risk, but this is unproven. The risk of as-
cending aortic thrombosis may be considered small, but we
believe, as others do, that coexistent renal artery occlusive
Fig 2. Ten-year survival among 52 chronic atherosclerotic ab-
dominal aortic occlusion (CAAAO) patients (Product-limit
method of Kaplan-Meier). The 3-, 5-, and 7-year survival are
86.6%, 76.5%, and 50.9%, respectively.disease and CAO is a dangerous combination.16,26Chronic thrombotic material that adheres and incorporates
intotheaorticwall at therenal artery level representsan important
technical challenge. Although techniques for thrombectomy
havebeendescribed toeradicate the thrombotic plug, it hasbeen
our experience that performing thrombectomywithmanual fin-
germaneuvers only partially removes thromboticmaterial adher-
ent to the aorta and the renal orifices and precludes treatment of
associated renal artery disease.6-8,13
When treating patients with CAAAO, a mandatory
assessment of the central aorta for pararenal disease with
CTA is critical in determining the extent of operative
procedure required to completely remove thrombus from
this aortic segment. We have found it essential to com-
pletely mobilize the pararenal aorta and place a vertical
suprarenal or surpamesenteric clamp to perform a complete
AR-TEA in those with evidence of pararenal thrombus.
Routine findings during dissection included dense inflam-
matory tissue involving the aortic wall, transmural aortic
calcifications, and adherent chronic pararenal thrombus;
however, in no case did these factors or the need for redo
aortic procedures become a deterrent to proceed with open
abdominal reconstruction.
Over the last decade, operative mortality outcomes after
aortic surgery have been reported primarily from studies on
infrarenal aneurysm repairs ranging from 2.7% to 5.8%.27-30
Reported mortality rates from surgical series of
CAAAO over the last three decades have ranged from 0% to
9%.6-8,22-24 In the two most current studies of predomi-
nately juxtarenal aortic occlusions, mortality rates were
reported at 5% and 5.6%, respectively.16,25 Evaluating re-
sults from large retrospective series of aorto-femoral recon-
structions for occlusive disease in the modern era reveals
reported mortality rates ranging between 2.5% and
4.5%.31-34 In the current report, there were no early deaths.
Low mortality may be related to the reduced mean age in
our study or a contemporary trend towards improved re-
sults with open aortic surgery.
In our cohort, postoperative renal insufficiency oc-
curred in 10 patients (18.9%). Similarly, in two contempo-
rary reviews of juxtarenal and pararenal aortic aneurysm
repairs, RIwas found to occur in 18% and22%, respectively.35,36
From these series, factors associated with postoperative
renal insufficiency were supravisceral clamping, renal vein
division, requirement of renal artery bypass, prolonged
operative times (351 minutes), and renal ischemic inter-
vals over 23 minutes. In a 25 year survey in one of the
largest series of aortofemoral reconstructions, RI occurred
in 17.5% (defined as serum Cr 1.5 mg/dL) of those
requiring renal artery procedures verses 0.7% of those with-
out.33 In our study, no particular factor could be identified
that increased the risk of developing postoperative renal
dysfunction. The presence of JRAO did not confer a signif-
icant risk for developing postoperative renal dysfunction;
however, a trend towards this complication was apparent.
An important limitation of our study is its retrospective
nature. While we observed some factors (patient character-
istics and operative variables) to be significantly associated
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between a factor and an outcome.
Endovascular treatment options for chronic aortic oc-
clusion at this juncture have been proven possible but may
have limitations in cases of proximal occlusion. Advances in
endovascular therapy for CAAAO will include overcoming
technical challenges and must prove durable over time
before being considered as the treatment of choice.
CONCLUSION
Abdominal aortic reconstruction is safe and effective in
treating CAAAO and is associated with low mortality and
acceptable morbidity. Suprarenal aortic clamping followed by
AR-TEA and aortic replacement is effective in many instances
of CAO and can be performed without significant renal im-
pairment. In our series, we have found no anatomic variant or
pathologic conditions that contraindicate such an approach.
These results may be used to compare future attempts to
broaden endolumenal indications to treat CAO.
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